Literature DB >> 12370098

Effect of magnesium lithospermate B on calcium and nitric oxide in endothelial cells upon hypoxia/reoxygenation.

Wei-Bo Luo1, Li Dong, Yi-Ping Wang.   

Abstract

AIM: To investigate the effect of magnesium lithospermate B (MLB) on hypoxia/ reoxygenation (H/R)-induced elevation of intracellular calcium concentration ([Ca2+]i) and nitric oxide (NO) release in endothelial cells.
METHODS: The cultured human umbilical vein endothelial cells (ECV304) were exposed to hypoxia for 30 min under 95 % N2 and 5 % CO2, then reoxygenation for 30 min under air and 5 % CO2. Cell injury was evaluated by dye exclusion test, superoxide dismutase (SOD) assay, and molondialdehyde (MDA) assay. [Ca2+]i was determined by Fura 2-AM. NO content was examined by a NO assay kit. Endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) mRNA expressions were measured by semi-quantitative RT-PCR.
RESULTS: Cell viability was decreased from (93.1+/-1.2) % in normoxia to (88+/-3) % in H/R (P < 0.01), and SOD activity was also decreased from (0.24+/-0.07) kNU/L to (0.18+/-0.03) kNU/L in H/R (P >0.05), but MDA production was increased from (1.12+/-0.06) mmol/L in normoxia to (3.78+/-0.03) mmol/L in H/R (P < 0.01) in ECV304 cultured under calcium conditions. MLB 2.5, 5, and 10 mg/L increased cell viability and SOD activity, and inhibited MDA formation in ECV304. H/R increased [Ca2+]i (F340/F380 from 1.65+/-0.16 to 1.89+/-0.28), NO release [from (7.5+/-1.3) micromol/L to (16+/-5) micromol/L], and eNOS mRNA expression, but decreased iNOS mRNA expression in ECV304 (P <0.05). However, it did not affect them under calcium-free conditions. MLB inhibited H/R-induced increases in [Ca2+]i and eNOS mRNA expression, stimulated NO release and iNOS mRNA expression (P <0.05).
CONCLUSION: MLB attenuates H/R-induced cell injury and increases NO release in ECV304. This increase of NO production is possibly associated with preventing cell injury induced by H/R in MLB-treated ECV304.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370098

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  7 in total

1.  The protective role of 5-HMF against hypoxic injury.

Authors:  Ming-Ming Li; Li-Ying Wu; Tong Zhao; Lei Xiong; Xin Huang; Zhao-Hui Liu; Xue-Lai Fan; Cheng-Rong Xiao; Yue Gao; Yun-Bao Ma; Ji-Jun Chen; Ling-Ling Zhu; Ming Fan
Journal:  Cell Stress Chaperones       Date:  2010-11-06       Impact factor: 3.667

2.  Magnesium lithospermate B protects the endothelium from inflammation-induced dysfunction through activation of Nrf2 pathway.

Authors:  Fei Gao; Jiao-Meng Li; Cong Xi; Hui-Hui Li; Ying-Luo Liu; Yi-Ping Wang; Li-Jiang Xuan
Journal:  Acta Pharmacol Sin       Date:  2019-01-07       Impact factor: 6.150

Review 3.  Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components.

Authors:  Wen-yu Wu; Yi-ping Wang
Journal:  Acta Pharmacol Sin       Date:  2012-09-03       Impact factor: 6.150

4.  Effects of salvianolate on microcirculatory disturbance in patients with stable coronary heart disease: study protocol for a randomized controlled trial.

Authors:  Zhanlu Li; Yi Luan; Min Wang; Ya Li; Xiaohua Shen; Guosheng Fu; Wenbin Zhang
Journal:  Trials       Date:  2021-03-08       Impact factor: 2.279

5.  The effectiveness of Salvianolate injection for in-stent restenosis after percutaneous coronary intervention: A protocol for systematic review and meta-analysis.

Authors:  Miao Zhang; Yue Yuan; Ying Gao; Ruozhu Lu; Yue Deng
Journal:  Medicine (Baltimore)       Date:  2022-04-22       Impact factor: 1.817

6.  Protective effect of magnesium acetyltaurate and taurine against NMDA-induced retinal damage involves reduced nitrosative stress.

Authors:  Azliana Jusnida Ahmad Jafri; Renu Agarwal; Igor Iezhitsa; Puneet Agarwal; Alexander Spasov; Alexander Ozerov; Nafeeza Mohd Ismail
Journal:  Mol Vis       Date:  2018-07-25       Impact factor: 2.367

7.  Cardiovascular effects of salvianolic Acid B.

Authors:  Jie Wang; Xingjiang Xiong; Bo Feng
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-10       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.